Nanobiotix S.A. (NBTX)
NASDAQ: NBTX
· Real-Time Price · USD
5.34
-0.42 (-7.29%)
At close: Jun 13, 2025, 2:53 PM
5.34
0.00%
After-hours: Jun 13, 2025, 04:00 PM EDT
-7.29% (1D)
| Bid | 4.75 |
| Market Cap | 251.79M |
| Revenue (ttm) | 42.2M |
| Net Income (ttm) | -33.47M |
| EPS (ttm) | -1.65 |
| PE Ratio (ttm) | -3.24 |
| Forward PE | -33.76 |
| Analyst | Buy |
| Ask | 6 |
| Volume | 11,920 |
| Avg. Volume (20D) | 11,481.6 |
| Open | 5.54 |
| Previous Close | 5.76 |
| Day's Range | 5.03 - 5.54 |
| 52-Week Range | 2.76 - 6.00 |
| Beta | 1.56 |
About NBTX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NBTX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NBTX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
+18.51%
Nanbotix shares are trading higher after the compa...
Unlock content with
Pro Subscription
4 months ago
+7.26%
Nanobiotix shares are trading higher after the company announced it began its Phase 2 trial for an innovative cancer treatment in stage 3 lung cancer.
